You are here
First Chief Named for the National Institute on Deafness and Other Communication Disorders' New Clinical Trials Branch
A. Julianna Gulya, M.D.
Otolaryngologist and scientist, A. Julianna Gulya, M.D. has become the first Chief of the National Institute on Deafness and Other Communication Disorders' (NIDCD) new Clinical Trials Branch. Dr. Gulya came to the NIDCD from Georgetown University Hospital Medical Center, Washington, D.C., where she was Professor of Otolaryngology - Head and Neck Surgery.
"The NIDCD is fortunate to have recruited such an accomplished scientist who also has a rich clinical background," said NIDCD Director, James B. Snow, Jr. He added that, "The NIDCD is enthusiastic about its new Clinical Trials Branch and is assured that with Dr. Gulya at the helm, the new branch will enhance the current treatment choices for diseases and disorders affecting hearing, balance, smell, taste, voice, speech and language."
Dr. Gulya received her M.D. degree with Distinction in Research in 1978 from the University of Rochester School of Medicine and Dentistry in Rochester, New York. She completed her surgical internship and junior surgical residency at the Beth Israel Hospital in Boston, Massachusetts. At the same time she held an appointment as a Clinical Fellow in Surgery at Harvard Medical School. Her otolaryngology residency was completed at the Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.
Prior to her Professorship in Otolaryngology - Head and Neck Surgery at the Georgetown University, Dr. Gulya had served at the Assistant and Associate Professor levels at the George Washington University School of Medicine, Washington, D.C. She remains a consultant in Otology-Neurotology at the Bethesda Naval Hospital, Bethesda, Maryland, and a consultant in Otology at the Walter Reed Army Medical Center, Washington, D.C.
Dr. Gulya has published on a variety of topics including sudden sensorineural hearing loss, endolymphatic hydrops and neoplasms affecting hearing and balance. Dr. Gulya is Associate Editor of the American Journal of Otology, and provides her expertise as a reviewer for several otolaryngology journals.
As the nation's focal point for research in human communication, the NIDCD conducts and supports biomedical and behavioral research and research training on normal mechanisms as well as diseases and disorders of hearing, balance, smell, taste, voice, speech and language. The NIDCD's new Clinical Trials Branch is responsible for overseeing the Institute's developing multicenter clinical trials cooperative groups. The cooperative groups will conduct much-needed randomized multicenter clinical trials to assess the efficacy of treatment for diseases and disorders of hearing, balance, smell, taste, voice, speech and language.